Automation of new methods for 18F incorporation into unactivated (hetero)arenes for translation to the clinic has progressed slowly. This protocol describes a workflow leading to automated radiosynthesis of the PARP inhibitor [18F]olaparib.
- Florian Guibbal
- Patrick G. Isenegger
- Véronique Gouverneur